Where does Infervision Medical Technology Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Infervision Medical Technology Co., Ltd. ranks #40,903 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Infervision Medical Technology Co., Ltd. hold?

Infervision Medical Technology Co., Ltd. holds 6 US utility patents granted between 2021 and 2025, spanning 7 technology areas.

What is Infervision Medical Technology Co., Ltd.'s Innovation Score?

Infervision Medical Technology Co., Ltd. has an Innovation Score of 31.7 out of 100 (39th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Infervision Medical Technology Co., Ltd. focus on?

Infervision Medical Technology Co., Ltd.'s top technology area is G06N (Computing Arrangements Based ON Specific Computational Models) with 5 patents, ranking #1,409 of 4,479 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Infervision Medical Technology Co., Ltd.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Infervision Medical Technology Co., Ltd..

What does claim depth mean for Infervision Medical Technology Co., Ltd.'s patents?

Infervision Medical Technology Co., Ltd.'s patents average 15.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Infervision Medical Technology Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Infervision Medical Technology Co., Ltd.

USPTO PatentsView assignee record - 6 granted patents across 7 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G06N (Computing Arrangements Based ON Specific Computational Models).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Infervision ranks #40,903 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 7 technology areas.

#40,903
of 49,997 US assignees by volume: 39th percentile
by Innovation Score (31.7/100): 15.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R40903 · Foreign Corporation #40,903 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #40,903/49,997
PHOTO-FINISH Industrial Turbine…
CPC-NARROW G06N · 7 areas
INNOV-THIN 31.7/100
CLAIMS-RICH 15.0 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Industrial Turbine Company (UK) Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Infervision’s 31.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (21%) Velocity 6.7 pts (21%) Breadth 9.4 pts (30%) Claim depth 9.0 pts (28%)

Qualcomm Incorporated · highest

85
Infervision Medical… · this assignee

32
3D Lighting… · lowest

7

What this shows Infervision's Innovation Score is 31.7/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Infervision?

Each dot is one of Infervision’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Infervision’s own 15.0 claims/patent is ABOVE the 14.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Infervision vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Infervision's grants concentrate

Infervision Medical Technology Co., Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 83.3% of grants classified under G06N (Computing Arrangements Based ON Specific Computational Models). By volume, Infervision sits between Industrial Turbine Company (UK) Limited and Infuze, LLC.

Infervision's three-year grant acceleration

Infervision Medical Technology Co., Ltd. shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Industrial Turbin…

6
Industrial Vacuum…

6
Industry-academic…

6
Industry-academic…

6
Infineon Bipolar…

6
Infinite Athlete

6
Infinity Canopy

6
Infuze

6
Infervision Medic… ◀

6

What this shows Infervision holds 6 patents at rank #40,973, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Infervision

By rank, the assignees closest to #40,973 in granted patent volume.

Leaders in G06N (Computing Arrangements Based ON Specific Computational Mo…)

Other assignees with the most granted patents in Infervision's primary technology class.

Infervision's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Infervision Medical Technology Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	2	33.3%
2024	2	33.3%
2025partial year	2	33.3%

Which technologies does Infervision Medical Technology Co., Ltd. patent most?

G06N - Computing Arrangements Based ON Specific Computational Models 5

G06T - Image Data Processing OR Generation, IN General 5

G06V - Image OR Video Recognition OR Understanding 2

A61B - DIAGNOSIS; SURGERY; Identification 2

G06F - Electric Digital Data Processing 2

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Infervision Medical Technology Co., Ltd.'s patent record in context - here's where to go next.

Infervision Medical Technology Co., Ltd.'s lead technology class is G06N (Computing Arrangements Based ON Specific Computational Models), 83.3% of its portfolio - see every assignee active in that class. Explore G06N
Ranked #40,903 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Infervision Medical Technology Co., Ltd. against Industrial Turbine Company (UK) Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.